Apyx Medical (NASDAQ:APYX) Announces Quarterly Earnings Results

Apyx Medical (NASDAQ:APYX) issued its quarterly earnings data on Thursday. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.01, Zacks reports. The business had revenue of $14.22 million for the quarter, compared to the consensus estimate of $13.39 million. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. Apyx Medical updated its FY 2025 guidance to EPS.

Apyx Medical Price Performance

NASDAQ:APYX opened at $1.04 on Friday. The firm has a market cap of $39.15 million, a price-to-earnings ratio of -1.25 and a beta of 1.18. Apyx Medical has a 12-month low of $0.93 and a 12-month high of $1.99. The company has a current ratio of 5.46, a quick ratio of 4.52 and a debt-to-equity ratio of 3.03. The company’s 50-day moving average is $1.42 and its two-hundred day moving average is $1.38.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.